Grove Bank & Trust’s Veracyte VCYT Stock Holding History

Grove Bank & Trust’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-94	Closed	-$2.1K	–	716
2023 Q3	$2.1K	Buy	+94	New	+$2.42K	﹤0.01%	641

Other funds holding VCYT

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Grove Bank & Trust's VCYT Position: Q4 2023 in Review

Grove Bank & Trust sold out of Veracyte (VCYT) in Q4 2023, closing a stake of 94 shares — an estimated $2.1K sold.

Grove Bank & Trust first reported a position in VCYT in Q3 2023 and held it in 1 quarter. The position peaked at $2.1K in Q3 2023. 250 funds tracked by Wall St. Rank hold VCYT as of Q4 2023.

Grove Bank & Trust reported no remaining Veracyte position as of Q4 2023 after selling out during the quarter.
Grove Bank & Trust sold 94 Veracyte shares in Q4 2023, an estimated $2.1K.
Grove Bank & Trust first reported a position in Veracyte in Q3 2023 and held it in 1 quarter.
Grove Bank & Trust's Veracyte position peaked at $2.1K in Q3 2023.
250 funds tracked by Wall St. Rank held Veracyte as of Q4 2023.

Based on Grove Bank & Trust's 13F filing for Q4 2023, filed 30 Jan 2024.